On February 26, 2024 Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, reported that Scott Hutton, Chief Executive Officer of Biodesix, will present and host in-person 1×1 investor meetings at the TD Cowen 44th Annual Health Care Conference, which will be held from March 4-6, 2024 (Press release, Biodesix, FEB 26, 2024, View Source [SID1234640479]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

TD Cowen 44th Annual Health Care Conference
Presentation Date: Monday, March 4, 2024
Presentation Time: 10:30 AM ET
Location: Marriot Copley Place, Boston, MA

The presentation will be webcast live and available for replay under "News & Events" in the Investors section of Biodesix’s website at Biodesix.com.